Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endosomal activation

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 3, 2011, Pages 653-661

  Hu, Lingzhi ^a   Zhang, Lei ^a   Chen, Junjie ^a   Lanza, Gregory M ^a   Wickline, Samuel A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

diffusion; endosome; longitudinal relaxation; macrophage; paramagnetic relaxation enhancement; perfluorocarbon nanoparticle

Indexed keywords

FLUORINE; FLUOROCARBON; MAGNETIC NANOPARTICLE; SURFACTANT;

ARTICLE; ENDOCYTOSIS; ENDOSOME; FLUORINE NUCLEAR MAGNETIC RESONANCE; MACROPHAGE; MOLECULAR IMAGING; MONTE CARLO METHOD; PHYSICAL MODEL; PRIORITY JOURNAL; THEORETICAL MODEL;

ANIMALS; CELL LINE; DIFFUSION; ENDOSOMES; FLUORINE; FLUOROCARBONS; MACROPHAGE ACTIVATION; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETITE NANOPARTICLES; MICE;

EID: 80051926408     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22656     Document Type: Article

References (48)

1. Kaneda MM, Caruthers S, Lanza GM, Wickline SA,. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng 2009; 37: 1922-1933.
2. Yu JX, Cui W, Zhao D, Mason RP,. Non-invasive physiology and pharmacology using 19f magnetic resonance. In:, Tressaud A, Haufe G, editors. Fluorine and health. Amsterdam: Elsevier BV; 2008. p 198-276.
3. Thomas S,. The biomedical applications of fluorine-19 nmr. In:, Partain C, Price R, Patton J, Kulkarni M, James A, editors. Magnetic resonance imaging. London: WB Saunders; 1988. p 1536-1552.
4. Wickline SA, Mason RP, Caruthers SD, et al. Fluorocarbon agents for multimodal molecular imaging and targeted therapeutics. In:, Weissleder R, Ross BD, Rehemtulla A, Gambhir SS, editors. Molecular imaging: principles and practice. Beijing: Peoples Medical Publishing House; 2010. p 542-573.
5. Winter PM, Schmieder AH, Caruthers SD, et al. Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. FASEB J 2008; 22: 2758-2767.
6. Winter PM, Morawski AM, Caruthers SD, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003; 108: 2270-2274. (Pubitemid 37363046)
7. Winter PM, Caruthers SD, Kassner A, et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha (nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003; 63: 5838-5843. (Pubitemid 37187482)
8. Partlow KC, Chen J, Brant JA, et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 2007; 21: 1647-1654. (Pubitemid 46855610)
9. Neubauer AM, Caruthers SD, Hockett FD, et al. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. J Cardiovasc Magn Reson 2007; 9: 565-573. (Pubitemid 46399012)
10. Caruthers SD, Neubauer AM, Hockett FD, et al. In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Invest Radiol 2006; 41: 305-312. (Pubitemid 44406192)
11. Morawski AM, Winter PM, Yu X, et al. Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles. Magn Reson Med 2004; 52: 1255-1262. (Pubitemid 39612813)
12. Flaim SF,. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 1043-1054. (Pubitemid 24291535)
13. Waters EA, Chen J, Yang X, et al. Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy. Magn Reson Med 2008; 60: 1232-1236.
14. Parhami P, Fung BM,. F-19 Relaxation study of perfluoro chemicals as oxygen carriers. J Phys Chem 1983; 87: 1928-1931.
15. Lee H, Price RR, Holburn GE, Partain CL, Adams MD, Cacheris WP,. In vivo fluorine-19 MR imaging: relaxation enhancement with Gd-DTPA. J Magn Reson Imaging 1994; 4: 609-613.
16. Neubauer AM, Myerson J, Caruthers SD, et al. Gadolinium-modulated F-19 signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magn Reson Med 2008; 60: 1066-1072.
17. Hodges MW, Cafiso DS, Polnaszek CF, Lester CC, Bryant RG,. Water translational motion at the bilayer interface: an NMR relaxation dispersion measurement. Biophys J 1997; 73: 2575-2579. (Pubitemid 27471466)
18. Polnaszek CF, Bryant RG,. Self-diffusion of water at the protein surface-a measurement. J Am Chem Soc 1984; 106: 428-429.
19. Berner B, Kivelson D,. Paramagnetically enhanced relaxation of nuclear spins-measurement of diffusion. J Phys Chem 1979; 83: 1401-1405.
20. Bloembergen N,. Proton relaxation times in paramagnetic solutions. J Chem Phys 1957; 27: 572-523.
21. Solomon I,. relaxation processes in a system of two spins. Phys Rev 1955; 99: 559-565.
22. Bloembergen N, Morgan LO,. Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation. J Chem Phys 1961; 34: 842-850.
23. Sharp RR,. Nuclear-spin relaxation in paramagnetic solutions-effects of large zero-field splitting in the electron-spin hamiltonian. J Chem Phys 1990; 93: 6921-6928.
24. Kruk D, Nilsson T, Kowalewski J,. Nuclear spin relaxation in paramagnetic systems with zero-field splitting and arbitrary electron spin. Phys Chem Chem Phys 2001; 3: 4907-4917. (Pubitemid 33078532)
25. Kruk D, Kowalewski J,. General treatment of paramagnetic relaxation enhancement associated with translational diffusion. J Chem Phys 2009; 130: 174104.
26. Belorizky E, Fries PH, Helm L, et al. Comparison of different methods for calculating the paramagnetic relaxation enhancement of nuclear spins as a function of the magnetic field. J Chem Phys 2008; 128: 052315.
27. Sharp R, Lohr L, Miller J,. Paramagnetic NMR relaxation enhancement: recent advances in theory. Prog Nucl Magn Reson Spectrosc 2001; 38: 115-158. (Pubitemid 32130384)
28. Partlow KC, Lanza GM, Wickline SA,. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. Biomaterials 2008; 29: 3367-3375.
29. Abragam A,. The principles of nuclear magnetism. Oxford: Clarendon Press; 1961. p 271-301.
30. Kodibagkar VD, Wang XH, Mason RP,. Physical principles of quantitative nuclear magnetic resonance oximetry. Front Biosci 2008; 13: 1371-1384. (Pubitemid 351594715)
31. Korb JP, Ahadi M, Zientara GP, Freed JH,. Dynamic effects of pair correlation-functions on spin relaxation by translational diffusion in two-dimensional fluids. J Chem Phys 1987; 86: 1125-1130.
32. Cherry RJ,. Rotational and lateral diffusion of membrane- proteins. Biochim Biophys Acta 1979; 559: 289-327.
33. Torrey HC,. Citation classic-nuclear-spin relaxation by translational diffusion. Phys Chem Earth 1984; 16: 16.
34. Winter P, Athey P, Kiefer G, et al. Improved paramagnetic chelate for molecular imaging with MRI. J Magn Magn Mater 2005; 293: 540-545. (Pubitemid 40608977)
35. Seymour JD, Caprihan A, Altobelli SA, Fukushima E,. Pulsed gradient spin echo nuclear magnetic resonance imaging of diffusion in granular flow. Phys Rev Lett 2000; 84: 266-269.
36. Giraudeau C, Flament J, Marty B, et al. A new paradigm for high-sensitivity 19F magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med 2010; 63: 1119-1124.
37. Xie W, Ludewig G, Wang K, Lehmler HJ,. Model and cell membrane partitioning of perfluorooctanesulfonate is independent of the lipid chain length. Colloid Surface B 2010; 76: 128-136.
38. Xie W, Bothun GD, Lehmler HJ,. Partitioning of perfluorooctanoate into phosphatidylcholine bilayers is chain length-independent. Chem Phys Lipids 2010; 163: 300-308.
39. Kaneda MM, Sasaki Y, Lanza GM, Milbrandt J, Wickline SA,. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. Biomaterials 2010; 31: 3079-3086.
40. Buffy JJ, Hong T, Yamaguchi S, Waring AJ, Lehrer RI, Hong M,. Solid-state NMR investigation of the depth of insertion of protegrin-1 in lipid bilayers using paramagnetic Mn2+. Biophys J 2003; 85: 2363-2373. (Pubitemid 37210786)
41. Liang B, Bushweller JH, Tamm LK,. Site-directed parallel spin-labeling and paramagnetic relaxation enhancement in structure determination of membrane proteins by solution NMR spectroscopy. J Am Chem Soc 2006; 128: 4389-4397.
42. Jackson JD,. Classical electrodynamics. New York: Wiley; 1962. 641 p.
43. Ellena JF, Obraztsov VV, Cumbea VL, Woods CM, Cafiso DS,. Perfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxation. J Med Chem 2002; 45: 5534-5542. (Pubitemid 35424971)
44. Freed JH,. Dynamic effects of pair correlation-functions on spin relaxation by translational diffusion in liquids.2. Finite jumps and independent T1 processes. J Chem Phys 1978; 68: 4034-4037.
45. Kok MB, de Vries A, Abdurrachim D, et al. Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles. Contrast Media Mol Imaging 2010; 6: 19-27.
46. Lee S-J, Olsen B, Schlesinger PH, Baker NA,. Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations. J Phys Chem B 2010; 114: 10086-10096.
47. Powell DH, NiDhubhghaill OM, Pubanz D, et al. Structural and dynamic parameters obtained from O-17 NMR, EPR, and NMRD studies of monomeric and dimeric Gd3+ complexes of interest in magnetic resonance imaging: an integrated and theoretically self consistent approach. J Am Chem Soc 1996; 118: 9333-9346. (Pubitemid 26355128)
48. Grebenkov DS,. NMR survey of reflected Brownian motion. Rev Mod Phys 2007; 79: 1077-1137. (Pubitemid 47357951)